Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia

Published:2002-12 Issue:12 Volume:40 Page:2125-2134
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Davidson Michael H,McGarry Thomas,Bettis Robert,Melani Lorenzo,Lipka Leslie J,LeBeaut Alexandre P,Suresh Ramachandran,Sun Steven,Veltri Enrico P

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference22 articles.

1. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486–97

2. Drug treatment of lipid disorders;Knopp;N Engl J Med,1999

3. Consensus for the use of fibrates in the treatment of dyslipoproteinemia and coronary heart disease;Fruchart;Am J Cardiol,1998

4. Plasma concentrations of active simvastatin acid are increased by gemfibrozil;Backman;Clin Pharmacol Ther,2000

5. Fatal rhabdomyolysis caused by lipid-lowering therapy;Federman;South Med J,2001

Cited by 480 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The clinical relevance of the reversal of coronary atherosclerotic plaque;European Journal of Internal Medicine;2024-08

2. Evolution of LDL-C lowering medications and their cardiovascular benefits: Past, present, and future;Current Problems in Cardiology;2024-07

3. Pharmacokinetics and Bioequivalence of Fixed‐Dose Combination of Simvastatin and Ezetimibe Tablets: A Randomized, Crossover, Open‐Label Study in Healthy Volunteers;Clinical Pharmacology in Drug Development;2024-05-15

4. Classical and Novel Lipid-Lowering Therapies for Diabetic Patients with Established Coronary Artery Disease or High Risk of Coronary Artery Disease—A Narrative Clinical Review;Pharmaceuticals;2024-04-29

5. Rapid screening of ternary amorphous formulations by a spray drying robot;International Journal of Pharmaceutics;2024-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3